We observed a statistically significantly increased proportion of TP53 mutation among the HCC tumour samples carrying SETDB1 copy number gain or overexpression (Fisher's exact test P=0.03; odds ratio=3.2, Fig. 2a,b). Here, TP53 is linked to hepatocellular carcinoma.